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Vaginal Delivery during Extracorporeal
Membrane Oxygenation: A Management
Strategy
Extracorporeal membrane oxygenation (ECMO) is
being used with increasing frequency to support
patients suffering from severe cardiac or respiratory
failure. In pregnancy, ECMO has resulted in favor-
able maternal and fetal outcomes.1 However, there
is a paucity of information regarding ECMO man-
agement in the peripartum period, including the
ideal method of delivery. A case series of four pa-
tients describes 100 per cent survival of the mother
and fetus where delivery was performed when the
patients were on ECMO.2 In all of these cases, de-
livery was performed via cesarean section. Further
investigation has revealed that all current informa-
tion available in regard to this topic describe delivery
via cesarean section only.1, 3, 4 Here, we describe a case
in which a vaginal delivery was successfully performed
when on ECMO, without significant blood loss or
circuit complication. We describe our management
strategies regarding maternal anticoagulation pre- and
postvaginal delivery.
In June 2016, a 30-year-old G8P2052 female at
30w4d presented with hypoxic respiratory failure
requiring mechanical ventilation, complicated by
barotrauma and resultant pnuemomediastinum and
subcutaneous emphysema. To reduce peak inspiratory
pressure, improve oxygenation, and reduce hypercap-
nia, the patient was placed on veno-venous ECMO
and subsequently placed on rest ventilator settings.
Flow rates of 4 to 4.5 L/min were achieved and the
sweep was titrated to PaCO2 between 30 and 35 mmHg.
On ECMO day 1, the patient developed vaginal
bleeding. Obstetric examination revealed a completely
dilated cervix and bulging membranes. Heparin was
held and blood products were made available at
bedside. Amniotomy was performed and fetal deceler-
ations to 90 beats/minute were noted on cardiotocog-
raphy. Operative delivery via forceps was performed
60 minutes after heparin cessation; rectal misoprostol
and a fibrinolytic agent (Amicar 1 g) were administered
after placental delivery. The uterus responded to in-
travenous Pitocin and fundal massage. The estimated
blood loss for the procedure was 500 mL, the upper
limits of normal for vaginal delivery. The patient
remained hemodynamically stable throughout the de-
livery and did not require transfusion of blood products.
Heparin infusion was restarted four hours after delivery
(held for five hours total) (see Fig. 1). Inspection of the
ECMO circuit and oxygenator did not reveal any visible
thrombus.
ECMO is a well-established modality for patients
with hypoxic respiratory failure who have failed
maximal conventional ventilation strategies. It has
been used successfully in pregnancy, with maternal
and fetal survival reported at 80 and 70 per cent,
respectively.1 Although delivery of the fetus is de-
ferred when possible, there are numerous reports of
successful caesarean delivery when on ECMO.1–4
Strategies for anticoagulation during operative interven-
tion on ECMO have been outlined in earlier reports.1
However, no data exist regarding vaginal delivery on
ECMO or optimal anticoagulation strategy.
Our outlined anticoagulation strategy (Fig. 1)
allowed for a successful operative vaginal delivery
without significant maternal hemorrhage or circuit
thrombotic complications after spontaneous labor
when on ECMO. This is the first documented case of
vaginal delivery with concomitant ECMO support.
Our experience can provide anticoagulation guidance
for other centers treating similar patients. The option for
vaginal delivery rather than caesarean section must be
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FIG. 1. Timeline of peripartum events and
associated anticoagulation strategy in our gravid
patient requiring ECMO who went into sponta-
neous labor on ECMO day 1.
